Monday Mar 10
MannKind: Follow The Smart Money
Attempts to drive down the price of MNKD stock will likely intensify in the lead up to April Fool's day.
Zacks Reiterates "Neutral" Rating for MannKind Corp.
's stock had its "neutral" rating reiterated by Zacks in a report issued on Thursday, Analyst Ratings.Net reports.
The Motley Fool
5 Questions for MannKind
That's somewhat understandable, with the upcoming Food and Drug Administration advisory committee meeting on April 1 reviewing Afrezza and hopefully a decision from the agency by April 15. Nevertheless, here are five questions that investors need to know the answers to and quotes from the prepared remarks answering the questions.
MannKind Corporation's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the MannKind Corporation fourth quarter 2013 conference call.
MannKind Corp. (MNKD) Releases Quarterly Earnings Results
MannKind Corp. issued its quarterly earnings data on Tuesday. The company reported earnings per share for the quarter, missing the analysts' consensus estimate of by $0.02, Analyst RN reports.
MannKind Corp. (MNKD) Set to Announce Earnings on Tuesday
MannKind Corp. is scheduled to post its quarterly earnings results on Tuesday, February 18th.